Captrust Financial Advisors Intellipharmaceutics International Inc. Transaction History

Captrust Financial Advisors

  • $30.9 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 17, 2020
SELL
$0.11 - $0.16 $16 - $24
-150 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$0.12 - $0.17 $18 - $25
150 New
150 $0
Q4 2019

Feb 14, 2020
SELL
$0.1 - $0.83 $0 - $7
-9 Closed
0 $0
Q2 2019

Aug 13, 2019
BUY
$0.18 - $0.32 $1 - $2
9 New
9 $0

About Intellipharmaceutics International Inc.

IPCIF Quotes by TradingView
  • Ticker IPCIF
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,092,700
  • Market Cap $4.96M
  • Description
  • Intellipharmaceutics International Inc., a pharmaceutical company, researches, develops, and manufactures novel and generic controlled-release and targeted-release oral solid dosage drugs in the United States. It develops various drug delivery systems, product candidates, and a pipeline of products based on its patented Hypermatrix technology in...
More about IPCIF
Track This Portfolio

Track Captrust Financial Advisors Portfolio

Follow Captrust Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email